SUTRO BIOPHARMA, INC. - FORM S-1/A - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - September 17, 2018

Attached files

file filename
EX-10.5 - 2018 EMPLOYEE STOCK PURCHASE PLAN AND FORMS OF AWARD AGREEMENTS - SUTRO BIOPHARMA, INC.d553197dex105.htm
S-1/A - S-1/A - SUTRO BIOPHARMA, INC.d553197ds1a.htm
EX-10.15 - MERCK LICENSE AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1015.htm
EX-10.13 - STANFORD LICENSE AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1013.htm
EX-10.11 - CELGENE LICENSE AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex1011.htm
EX-10.4 - 2018 EQUITY INCENTIVE PLAN AND FORMS OF AWARD AGREEMENTS - SUTRO BIOPHARMA, INC.d553197dex104.htm
EX-10.1 - FORM OF INDEMNITY AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex101.htm
EX-5.1 - OPINION OF FENWICK & WEST LLP - SUTRO BIOPHARMA, INC.d553197dex51.htm
EX-3.4 - POST-IPO BYLAWS - SUTRO BIOPHARMA, INC.d553197dex34.htm
EX-3.2 - POST-IPO CERTIFICATE OF INCORPORATION - SUTRO BIOPHARMA, INC.d553197dex32.htm
EX-3.1 - PRE-IPO CERTIFICATE OF INCORPORATION - SUTRO BIOPHARMA, INC.d553197dex31.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - SUTRO BIOPHARMA, INC.d553197dex11.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 1, 2018 (except for the third paragraph of Note 1 and for Note 14, as to which the date is September 17, 2018) in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-227103) and related Prospectus of Sutro Biopharma, Inc. dated September 17, 2018.

/s/ Ernst & Young LLP

Redwood City, California

September 17, 2018

SUTRO BIOPHARMA, INC. Reports